cyanidin has been researched along with durapatite in 1 studies
| Studies (cyanidin) | Trials (cyanidin) | Recent Studies (post-2010) (cyanidin) | Studies (durapatite) | Trials (durapatite) | Recent Studies (post-2010) (durapatite) |
|---|---|---|---|---|---|
| 388 | 1 | 289 | 17,101 | 522 | 7,832 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Li, X; Lin, X; Liu, M; Liu, Q; Pavlos, NJ; Tan, Z; Tickner, J; Wang, T; Xu, J; Zhao, J; Zhou, L | 1 |
1 other study(ies) available for cyanidin and durapatite
| Article | Year |
|---|---|
Cyanidin Chloride inhibits ovariectomy-induced osteoporosis by suppressing RANKL-mediated osteoclastogenesis and associated signaling pathways.
Topics: Animals; Anthocyanins; Bone Density Conservation Agents; Calcium Signaling; Disease Models, Animal; Dose-Response Relationship, Drug; Durapatite; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Mice; Mice, Inbred C57BL; NF-kappa B; NF-KappaB Inhibitor alpha; NFATC Transcription Factors; Osteoclasts; Osteogenesis; Osteoporosis, Postmenopausal; Ovariectomy; Phosphorylation; Proteolysis; Proto-Oncogene Proteins c-fos; RANK Ligand; RAW 264.7 Cells | 2018 |